Related Experiment Videos
Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice
Jan Matthes1, Leyla Yildirim, Georg Wietzorrek
1Department of Pharmacology, University of Cologne, Gleueler Strasse 24, 50931 Cologne, Germany.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|May 18, 2004
Summary
Cav1.3 channels are crucial for heart rhythm, not ventricular function. Their absence causes bradycardia and AV node dysfunction, impacting cardiac electrophysiology and drug development.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Ion Channel Function
Background:
- Cardiac L-type calcium channels (Cav1.2 and Cav1.3) regulate heart function.
- Cav1.3 channels are highly expressed in the sino-atrial node (SAN) and atria, unlike Cav1.2.
- Cav1.3 knockout mice exhibit bradycardia, suggesting a role in cardiac rhythm.
Purpose of the Study:
- To investigate the functional role of Cav1.3 channels in the working heart.
- To determine the impact of Cav1.3 suppression on ventricular contractility and cardiac electrophysiology.
- To explore Cav1.3 as a potential pharmacological target for bradycardic agents.
Main Methods:
- Utilized isolated working hearts from wild-type and Cav1.3 knockout mice.
- Performed histological analysis to assess cardiac pathology.
- Recorded electrocardiograms (ECGs) and measured ventricular contractility.
- Assessed the effects of isoproterenol on cardiac function and electrophysiology.
Main Results:
- Cav1.3 knockout hearts showed no pathological changes and maintained normal ventricular contractility.
- Severe sinus bradycardia and ventricular extrasystoles were observed in Cav1.3 knockout hearts, partially improved by isoproterenol.
- Delayed atrio-ventricular (AV) conduction and a decoupling of heart rate and PR interval were evident.
- Isoproterenol did not ameliorate the AV conduction disturbances.
Conclusions:
- Cav1.3 channel suppression does not impair ventricular contractile function.
- Reduced sinus node frequency is compensated by adrenergic stimulation, but AV node dysfunction persists.
- Bradyarrhythmia in Cav1.3 deficient hearts involves intrinsic AV node dysfunction resistant to adrenergic effects.
- Findings predict the clinical presentation of selective Cav1.3 blockade.